TAFASITAMAB for B-cell lymphoma recurrent: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 5 adverse event reports in the FDA FAERS database where TAFASITAMAB was used for B-cell lymphoma recurrent.

Most Reported Side Effects for TAFASITAMAB

Side Effect	Reports	%	Deaths	Hosp.
Disease progression	470	33.8%	239	54
Diffuse large b-cell lymphoma	346	24.9%	206	37
Off label use	203	14.6%	43	73
Death	146	10.5%	146	18
Neutropenia	99	7.1%	19	45
Covid-19	96	6.9%	33	57
General physical health deterioration	75	5.4%	33	33
Pneumonia	66	4.7%	28	45
Febrile neutropenia	64	4.6%	7	55
Drug ineffective	62	4.5%	40	5
Thrombocytopenia	60	4.3%	13	20
Lymphoma	57	4.1%	7	3
Malignant neoplasm progression	47	3.4%	17	12
Infection	42	3.0%	8	14
Diarrhoea	39	2.8%	5	14